SLMAP Gene Brugada Syndrome Type 9 Genetic Test in UAE | 2800 AED

Executive Summary & Core Metrics

Executive Summary

Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO-accredited NGS processing for SLMAP coding and deep intronic variants.
Premium Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic post-test clinical guidance in result interpretation by DHA-licensed Consultant Medical Genetics.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The SLMAP Gene Brugada Syndrome Type 9 Genetic Test screens for pathogenic variants in the SLMAP gene associated with Brugada syndrome, a potentially life-threatening cardiac channelopathy. This analysis aids in diagnosis, risk stratification, and family cascade testing. Targeted next-generation sequencing (NGS) of the SLMAP coding region and flanking intronic regions is performed at high depth to detect single nucleotide variants, insertions/deletions, and splice-site alterations.

Test Comparison: Our Approach vs. Alternatives

Feature	Our Test (SLMAP NGS)	Standard Brugada Panel (SCN5A only)	Whole Exome Sequencing
Method	NGS – focused high-depth SLMAP analysis	Limited to SCN5A gene	Broad exome capture, lower coverage per gene
Diagnostic Sensitivity	99.9% for SLMAP coding variants (incl. deep intronic)	Misses ~30% Brugada-linked genes	Variable; incidental findings risk
Turnaround Time	3–4 Weeks	2–5 Weeks	8–12 Weeks
Price (AED)	2,800	2,200–3,000	4,500–8,000

Physician Insight & Safety Protocols

“As a Consultant Medical Genetics licensed by DHA (No. 9294403), I emphasize that SLMAP genetic testing is not a standalone verdict. It must be integrated with clinical evaluation, 12-lead ECG, Holter monitoring, and family history. Genetic findings refine risk stratification and guide management — they are not a substitute for urgent cardiology assessment.”

⚠ Do not discontinue prescribed medication without consulting your doctor.

Advisory

If you experience syncope, recurrent palpitations, or documented ventricular arrhythmias, seek immediate medical attention. This test is intended for individuals with a clinical indication or referral from a cardiologist or geneticist. Self-testing without a documented reason is strongly discouraged.

Exclusion Criteria & Red Flags

Individuals currently admitted with acute arrhythmic storm or haemodynamic instability must stabilize before testing; this is not an emergency genetic diagnosis.
If you have a known pathogenic variant in another Brugada-related gene (e.g., SCN5A), consult your physician to determine if SLMAP sequencing is still warranted.
Patients with implantable cardioverter-defibrillators (ICDs) may proceed with testing but must coordinate blood draw with their electrophysiologist.

Patient FAQ & Clinical Guidance

1. Is the SLMAP gene test necessary if I have a normal ECG?

Yes, Brugada syndrome ECG patterns can be episodic; a normal ECG does not rule out genetic susceptibility. A pathogenic SLMAP variant confirms the diagnosis and guides surveillance and family screening even with a normal resting ECG.

2. How long does it take to receive my results?

Our laboratory delivers SLMAP gene sequencing results within three to four weeks, including expert interpretation and clinical correlation. Complex variants may require additional confirmation, but you will be informed promptly.

3. What sample types do you accept and how is collection done?

We accept whole blood, extracted DNA, or a single blood drop on an FTA card. All can be collected via our VIP mobile phlebotomy service with temperature-controlled cold-chain transport for optimal nucleic acid stability.

UAE Regulatory & Data Privacy Adherence

Regulatory Compliance

This service strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data remains sovereign within UAE-authorized infrastructure. Processing is performed under ISO 9001:2015 Certified Facility (Cert: INT/EGQ/2509DA/3139).

Clinical & Logistical Metadata

Test Name	SLMAP Gene Brugada Syndrome Type 9 Genetic Test
Price (AED)	2,800
Turnaround Time	3–4 Weeks
Sample Type / Matrix	Whole blood (EDTA), extracted DNA, or FTA card
Methodology Used	Targeted next-generation sequencing (NGS) of SLMAP coding region and flanking intronic regions
ICD-10-CM Code	I49.81 (Brugada syndrome)
LOINC Code	94219-6 (Brugada syndrome gene panel)
DHA Facility License & Laboratory Address	License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE)